Bankrupt drugmaker Purdue Pharma filed a new bankruptcy plan on Tuesday, a major step toward finalizing a proposed opioid ...
Bankrupt opioid manufacturer Purdue and the Sackler family have agreed to a $7.4 billion settlement to resolve opioid claims ...
(Billable Hours is Reuters' weekly report on lawyers and money. Please send tips or suggestions to ...
Purdue Pharma, the pharmaceutical company responsible for OxyContin, has recently filed a new bankruptcy plan outlining a ...
Purdue Pharma headquarters at 201 Tresser Boulevard in Stamford. STAMFORD – Purdue Pharma L.P.’s owners will distribute about ...
Purdue Pharma has filed a new bankruptcy plan as part of a $7.4 billion settlement to resolve thousands of lawsuits over the ...
Purdue Pharma has submitted a revised Chapter 11 bankruptcy plan proposing more than $7.4 billion in cash payments to ...
Purdue Pharma asked a bankruptcy judge late Tuesday to consider the latest version of its plan to settle thousands of lawsuits over the toll of the powerful prescription painkiller OxyContin, a deal ...
The Associated Press on MSN12d
Purdue Pharma submits opioid lawsuit settlement plan, including up to $7 billion cash from SacklersCopyright 2025 The Associated Press. All Rights Reserved. Updated [hour]:[minute] [AMPM] [timezone], [monthFull] [day], [year ...
Purdue Pharma has filed a new bankruptcy plan that details how the funds will be allocated and the proportion paid by its owners, nearly two months after agreeing to a $7.4bn opioid settlement.
In Harrington v. Purdue Pharma L.P., the Supreme Court held that the Bankruptcy Code does not authorize a bankruptcy court to ...
Purdue Pharma on Wednesday filed a new bankruptcy reorganization plan to resolve mass lawsuits alleging that the OxyContin maker and its Sackler family owners contributed to the opioid crisis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results